Harvest One Cannabis Inc (OTCMKTS:HRVOF) closed Thursday’s trading session at $0.53 representing a noteworthy gain following the European launch of its reformulated Satipharm CBD capsules just a few weeks ago.
The company announced the end of January 2019 revealed that it was kicking things into high gear by launching the Satipharm CBD capsules in the European market. The Satipharm 10mg CBD Gelpell® capsules will thus be Harvest One Cannabis’ first product to be launched in the UK where it is expected to deliver superior quality and biodiversity. The company is expected to distribute the capsules to major retailers in the UK and also in the European Union. It also plans to kick off distribution in Canada sometime in the future.
“We are delighted with the launch of Satipharm’s new website and eCommerce platform, making our clinically proven CBD Gelpell® capsules available to consumers across Europe,” stated Satipharm President Jonathan Hartshorn.
Harvest One is working on the expansion of its wellness strategy
Hartshorn also noted that the company is confident that consumers will embrace the CBD Gelpell® capsules given the company’s increasing focus on superior biodiversity, GMP certified products, and consumer education. Harvest One CEO Grant Froese noted that the launch of the CBD Gelpell capsules highlights a key part of his company’s wellness strategy.
Froese also stated that Harvest One is excited to offer the innovative CBD Gelpell® capsules to the market. The company also expects to launch more products in the future as part of its plans to expand the wellness strategy in different markets across the globe. The UK represents one of the largest global markets, and thus the recent product launch highlights a key milestone for the company.
The country is a major gateway into the European market and penetration in the UK might provide the product with the necessary exposure to warrant demand from other markets in the region. The launch of the Satipharm CBD capsules in Europe will also help Harvest One to evaluate the market and determine whether its other products are well suited for the market and how they will fair.